Clinical Trials Directory

Trials / Completed

CompletedNCT05876026

MRI T1 Relaxation Time in Rectal Cancer

MRI T1 Relaxation Times in Evaluating Neoadjuvant Treatment of Rectal Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
Vejle Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about the T1 relaxation time and T1 relaxation time properties of the disease in people with locally advanced rectal cancer. The main question it aims to answer is: Does MRI T1 relaxation time have a high diagnostic performance in recognizing fibrosis as a complete response to neoadjuvant treatment of rectal cancer? Participants will receive standard neoadjuvant treatment and be part of the standard examination programme regarding rectal cancer.

Conditions

Timeline

Start date
2023-05-08
Primary completion
2025-10-31
Completion
2025-12-31
First posted
2023-05-25
Last updated
2026-01-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05876026. Inclusion in this directory is not an endorsement.